EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical features of immunodeficiency and severe infection in VEXAS syndrome: a case series

Justin Smith, Dylan Johnson, Mohammed Osman, Jason Soo, Stephanie Keeling

Discover Medicine · 17.04.2026 · 3 (1)

DOI: 10.1007/s44337-026-00604-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Medicine, online erschienen am 17.04.2026. Verfasst von Justin Smith und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

VEXAS syndrome is a recently described X-linked somatic autoinflammatory syndrome which manifests with exaggerated hyperinflammation, an MDS-like syndrome, and probable immunodeficiency.

Objective

The objective of this study is to describe the clinical presentation and outcomes of patients with VEXAS syndrome with a focus on immunodeficiency and infectious complications.

Methods

We performed a retrospective case analysis of VEXAS patients seen in our center and a surrounding immunodeficiency and infectious complications.

Results

We identified five patients who were diagnosed with VEXAS syndrome between 2021 and 2023. All patients had autoinflammatory syndromes, UBA1 mutations, and characteristic vacuolization on bone marrow biopsy, while none met the criteria for MDS. Infectious complications were identified in all patients at the time of diagnosis. At presentation, patient 1 had Klebsiella pneumoniae bacteremia, patient 2 had disseminated nocardiosis, patient 3 had community acquired pneumonia (CAP), patient 4 had disseminated histoplasmosis, and patient 5 had CAP complicated by cavitary pulmonary lesions. Lymphocyte subset measurements revealed a reduced frequency of circulating effector T and B lymphocytes. All patients received corticosteroids and tocilizumab once infection was treated.

Conclusion

We identified severe infections in five patients associated with peripheral B and T cell depletion. UBA1-mutations may directly contribute to infection risk through monocyte dysfunction and lymphocyte depletion. Future research should aim to establish the utility of infection prophylaxis.

Zitieren

APA

Smith, J., Johnson, D., Osman, M., Soo, J., & Keeling, S. (2026). Clinical features of immunodeficiency and severe infection in VEXAS syndrome: a case series. Discover Medicine, 3(1). https://doi.org/10.1007/s44337-026-00604-w

Vancouver

Smith J, Johnson D, Osman M, Soo J, Keeling S. Clinical features of immunodeficiency and severe infection in VEXAS syndrome: a case series. Discover Medicine. 2026;3(1). doi:10.1007/s44337-026-00604-w

BibTeX
@article{Smith2026,
  author = {Smith, Justin and Johnson, Dylan and Osman, Mohammed and Soo, Jason and Keeling, Stephanie},
  title = {Clinical features of immunodeficiency and severe infection in VEXAS syndrome: a case series},
  journal = {Discover Medicine},
  year = {2026},
  volume = {3},
  number = {1},
  doi = {10.1007/s44337-026-00604-w}
}
Kostenlos starten →